e-learning
resources
London 2016
Tuesday, 06.09.2016
Biomarkers and phenotypes of COPD and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypogonadism as a factor influencing health condition in COPD patients
Renata Rubinsztajn (Warszawa, Poland), Renata Rubinsztajn, Tadeusz Przybylowski, Marta Maskey-Warzechowska, Krzysztof Kartwat, Ryszarda Chazan
Source:
International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Session:
Biomarkers and phenotypes of COPD and comorbidities
Session type:
Poster Discussion
Number:
4616
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Renata Rubinsztajn (Warszawa, Poland), Renata Rubinsztajn, Tadeusz Przybylowski, Marta Maskey-Warzechowska, Krzysztof Kartwat, Ryszarda Chazan. Hypogonadism as a factor influencing health condition in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 4616
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Recruitment for psychological therapy in chronic obstructive pulmonary disease (COPD) What factors influence participation?
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Is COPD an independent predictor of osteoporosis?
Source: International Congress 2015 – COPD: notable points
Year: 2015
How beneficial might be using the Lüscher colour test in the psychological assessment of COPD patients?
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Metabolic risk factors in patients with advanced COPD and the response to short-term high-intensity pulmonary rehabilitation
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Sarcopenia and associated factors in older adults with COPD: Results from the SABE-Bogota cohort study
Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2016
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Impaired health status in primary care COPD patients is underestimated
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept